Jane Street’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Sell |
8,006
-27,922
| -78% | -$941K | ﹤0.01% | 4419 |
|
|
2025
Q1 | $1.14M | Buy |
35,928
+2,577
| +8% | +$81.9K | ﹤0.01% | 2895 |
|
|
2024
Q4 | $1.3M | Buy |
33,351
+1,555
| +5% | +$60.4K | ﹤0.01% | 2632 |
|
|
2024
Q3 | $1.43M | Sell |
31,796
-4,138
| -12% | -$186K | ﹤0.01% | 2884 |
|
|
2024
Q2 | $1.5M | Buy |
35,934
+23,941
| +200% | +$1,000K | ﹤0.01% | 3118 |
|
|
2024
Q1 | $546K | Sell |
11,993
-136,211
| -92% | -$6.2M | ﹤0.01% | 3951 |
|
|
2023
Q4 | $6.85M | Buy |
148,204
+136,436
| +1,159% | +$6.31M | ﹤0.01% | 1218 |
|
|
2023
Q3 | $479K | Buy |
+11,768
| New | +$479K | ﹤0.01% | 3644 |
|
|
2023
Q1 | – | Sell |
-9,517
| Closed | -$482K | – | 5807 |
|
|
2022
Q4 | $482K | Buy |
+9,517
| New | +$482K | ﹤0.01% | 3442 |
|
|
2022
Q2 | – | Sell |
-9,581
| Closed | -$576K | – | 5812 |
|
|
2022
Q1 | $576K | Buy |
+9,581
| New | +$576K | ﹤0.01% | 3574 |
|
|
2021
Q1 | – | Sell |
-23,124
| Closed | -$2.19M | – | 5113 |
|
|
2020
Q4 | $2.19M | Buy |
23,124
+14,464
| +167% | +$1.37M | ﹤0.01% | 1346 |
|
|
2020
Q3 | $623K | Buy |
+8,660
| New | +$623K | ﹤0.01% | 2238 |
|
|
2020
Q1 | – | Sell |
-7,645
| Closed | -$477K | – | 3628 |
|
|
2019
Q4 | $477K | Buy |
+7,645
| New | +$477K | ﹤0.01% | 2285 |
|
|
2019
Q3 | – | Sell |
-6,304
| Closed | -$381K | – | 3633 |
|
|
2019
Q2 | $381K | Buy |
+6,304
| New | +$381K | ﹤0.01% | 2524 |
|